Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Key Takeaway: Enovis Corporation has announced that key executives will present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024. This presentation will be led by President and COO Brady Shirley, CFO Ben Berry, and Group President Louis Vogt. A link to a live audio webcast and a replay will be available on the company's website. Enovis emphasizes its commitment to developing innovative medical technologies aimed at improving patient outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is recognized as an innovation-driven medical technology growth company.
  • The upcoming presentation indicates active engagement and transparency with investors.
  • The webcast will allow a broader audience to access the presentation, enhancing visibility.
  • Enovis is focused on developing solutions for better patient outcomes.

Full Press Release Details

Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben Berry, CFO, and Louis Vogt, Group President Recon will present at the Canaccord Genuity Musculoskeletal Conference. The presentation is scheduled to begin at 5:30pm p.m. ET (2:30 p.m. PT) on Monday, February 12, 2024.
A link to the live audio webcast, as well as a replay of this event, will be available on the company’s website at Events and Presentations.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.
Vice President, Investor Relations

Frequently Asked Questions

When is Enovis Corporation's presentation at the conference?

The presentation is on February 12, 2024, at 5:30 PM ET.

Who will present Enovis Corporation at the musculoskeletal conference?

Presenters include Brady Shirley, Ben Berry, and Louis Vogt.

Where can I find the live webcast of the event?

The live audio webcast will be available on the Enovis website.

What is Enovis Corporation focused on?

Enovis develops clinically differentiated medical technology solutions.

What stock exchange lists Enovis Corporation shares?

Enovis Corporation is listed on the New York Stock Exchange under ENOV.

Last updated: Feb 7, 2024